No Data
No Data
Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Analysis and Forecast Report 2024, With Focus on BGI Genomics and Annoroad Gene Technology
A model for the integration of precision medical and technology, bgi genomics (300676.SZ) received the "Annual Outstanding Big Health Enterprise" award.
Health is not only the foundation of individual quality of life, but also an important factor for social stability and economic development. Today, with the improvement of living standards and the enhancement of health awareness, people's attention to health issues has reached unprecedented heights. In the face of this global trend, many companies are entering the big health industry, committed to improving the quality and efficiency of medical services through technological innovation to meet the growing health needs of people. Against this background, bgi genomics (300676.SZ) has demonstrated outstanding performance in the deep integration of technological innovation and precision medical.
Japan Non-Invasive Prenatal Testing Market Size, Trends, Growth and Forecasts 2024-2032 With Competitive Analysis of SR, BGI Genomics, Macrogen Japan, and LSI Medience - ResearchAndMarkets.com
Express News | Summary of shareholding reductions by listed companies on November 25th (table)
Express News | bgi genomics: The controlling shareholder plans to reduce its shareholding in the company by no more than 2%.
Express News | bgi genomics established a biotechnology company in Shijiazhuang.
No Data